These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25099476)

  • 41. Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography.
    Roth C; Gangl C; Dalos D; Delle-Karth G; Neunteufl T; Berger R
    J Interv Cardiol; 2018 Dec; 31(6):780-791. PubMed ID: 30479028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optical coherence tomography analysis of the stenting of saphenous vein graft (SOS) Xience V Study: use of the everolimus-eluting stent in saphenous vein graft lesions.
    Papayannis AC; Michael TT; Yangirova D; Abdel-Karim AR; Kohlhaas J; Mahmood A; Addo T; Haagen D; Makke L; Roesle M; Rangan B; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2012 Aug; 24(8):390-4. PubMed ID: 22865309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome.
    Karjalainen P; Paana T; Ylitalo A; Sia J; Nammas W
    Acta Radiol; 2017 Sep; 58(9):1077-1084. PubMed ID: 28273737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
    Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
    Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris.
    Mizoguchi T; Sawada T; Shinke T; Yamada S; Okamoto H; Kim SS; Takarada A; Yasaka Y
    Int J Cardiol; 2014 Feb; 171(2):224-30. PubMed ID: 24388538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the safety and efficacy of biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents: propensity score-matched analysis.
    Lee JH; Lee JW; Youn YJ; Ahn MS; Ahn SG; Kim JY; Yoo BS; Lee SH; Choi E; Yoon J
    J Interv Cardiol; 2014 Aug; 27(4):399-407. PubMed ID: 25052960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stents.
    Guagliumi G; Shimamura K; Sirbu V; Garbo R; Boccuzzi G; Vassileva A; Valsecchi O; Fiocca L; Canova P; Colombo F; Tensol Rodriguez Pereira G; Nakamura D; Attizzani GF; Cereda A; Satogami K; De Luca L; Saia F; Capodanno D
    Eur Heart J; 2018 Jul; 39(26):2448-2456. PubMed ID: 29788263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of drug eluting stent biocompatibility between third generation NOBORI biolimus A9-eluting stent and second generation XIENCE V everolimus-eluting stent in a porcine coronary artery model.
    Sumida A; Gogas BD; Nagai H; Li J; King SB; Chronos N; Hou D
    Cardiovasc Revasc Med; 2015 Sep; 16(6):351-7. PubMed ID: 26294337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-year vessel healing after everolimus-eluting stent implantation: serial assessment by optical coherence tomography.
    Taniguchi Y; Otake H; Shinke T; Nakagawa M; Hariki H; Inoue T; Osue T; Hiranuma N; Nishio R; Kinutani H; Iwasaki M; Konishi A; Kuroda M; Hirata K
    J Cardiol; 2015 Apr; 65(4):298-304. PubMed ID: 25082295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model.
    Nakazawa G; Shinke T; Ijichi T; Matsumoto D; Otake H; Torii S; Hiranuma N; Ohsue T; Otsuka F; Shite J; Hirata K; Ikari Y
    EuroIntervention; 2014 Oct; 10(6):717-23. PubMed ID: 25330504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Neointimal Response between Durable-Polymer Everolimus-Eluting Stent and Bioabsorbable-Polymer Everolimus-Eluting Stent for Severely Calcified Lesions Requiring Rotational Atherectomy.
    Matsuda Y; Ashikaga T; Sasaoka T; Hatano Y; Umemoto T; Lee T; Yonetsu T; Maejima Y; Sasano T
    Int Heart J; 2020 Jul; 61(4):665-672. PubMed ID: 32684594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study.
    Barlis P; Regar E; Serruys PW; Dimopoulos K; van der Giessen WJ; van Geuns RJ; Ferrante G; Wandel S; Windecker S; van Es GA; Eerdmans P; Jüni P; di Mario C
    Eur Heart J; 2010 Jan; 31(2):165-76. PubMed ID: 19889649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents.
    Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):269-77. PubMed ID: 25345751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two-year clinical outcomes of the NOBORI biolimus-eluting stents versus XIENCE/PROMUS everolimus-eluting stents in small vessel disease.
    Jinnouchi H; Kuramitsu S; Shinozaki T; Hiromasa T; Kobayashi Y; Morinaga T; Yamaji K; Soga Y; Shirai S; Ando K
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):E132-E138. PubMed ID: 26708085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
    Sotomi Y; Onuma Y; Dijkstra J; Miyazaki Y; Kozuma K; Tanabe K; Popma JJ; de Winter RJ; Serruys PW; Kimura T
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):59-66. PubMed ID: 28158421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT Trial.
    Natsuaki M; Watanabe H; Morimoto T; Kozuma K; Kadota K; Muramatsu T; Nakagawa Y; Akasaka T; Hanaoka KI; Tanabe K; Morino Y; Ishikawa T; Katoh H; Nishikawa H; Tamura T; Ono K; Yamamoto K; Ishihara T; Abe M; Taniguchi R; Ikari Y; Okada K; Kimura T
    EuroIntervention; 2023 Aug; 19(5):e402-e413. PubMed ID: 37395475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.
    Oda T; Okamura T; Yamada J; Miyagi N; Uehara H; Nao T; Tateishi H; Maeda T; Nakamura T; Shiraishi K; Nakashima T; Nishimura S; Miura T; Matsuzaki M; Yano M
    Heart Vessels; 2016 Apr; 31(4):449-56. PubMed ID: 25614415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study.
    Ishida K; Otsuki S; Giacchi G; Ortega-Paz L; Shiratori Y; Freixa X; Martín-Yuste V; Masotti M; Sabaté M; Brugaletta S
    Cardiovasc Revasc Med; 2017; 18(1):47-52. PubMed ID: 27634493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.